Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2010 | Q4 2009 |
|---|---|---|
| Revenue | $65.52M | $33.89M |
| Net Income | -$180.39M | -$158.64M |
| EPS Diluted | -$0.90 | -$0.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR